BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28891831)

  • 21. Comparison of Cytokine and Efflux Transporter Expression in Pediatric Versus Adult-onset Ulcerative Colitis.
    Savić Mlakar A; Hojsak I; Jergović M; Vojvoda Parčina V; Babić Ž; Troskot B; Mihaljević Ž; Bendelja K
    J Pediatr Gastroenterol Nutr; 2017 Jun; 64(6):943-948. PubMed ID: 27622899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
    Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ulcerative colitis with hepatitis B virus infection treated successfully by granulocyte monocyte apheresis.
    Saito H; Hanafusa N; Kishikawa J; Noiri E; Sunami E; Ishihara S; Watanabe T; Nangaku M
    J Clin Apher; 2016 Dec; 31(6):584-586. PubMed ID: 26876484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte/Monocyte Adsorptive Apheresis in Moderate to Severe Ulcerative Colitis--Effective or Not?
    Kruis W; Nguyen P; Morgenstern J
    Digestion; 2015; 92(1):39-44. PubMed ID: 26112696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colonic mucosal and cytobrush sample cytokine mRNA expression in canine inflammatory bowel disease and their correlation with disease activity, endoscopic and histopathologic score.
    Konstantinidis AO; Adamama-Moraitou KK; Pardali D; Dovas CI; Brellou GD; Papadopoulos T; Jergens AE; Allenspach K; Rallis TS
    PLoS One; 2021; 16(1):e0245713. PubMed ID: 33471872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis.
    Rismo R; Olsen T; Cui G; Christiansen I; Florholmen J; Goll R
    Scand J Gastroenterol; 2012 May; 47(5):538-47. PubMed ID: 22486187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression.
    Diab J; Al-Mahdi R; Gouveia-Figueira S; Hansen T; Jensen E; Goll R; Moritz T; Florholmen J; Forsdahl G
    Inflamm Bowel Dis; 2019 Feb; 25(3):490-497. PubMed ID: 30476077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus.
    Fukuchi T; Nakase H; Matsuura M; Yoshino T; Toyonaga T; Ohmori K; Ubukata S; Ueda A; Eguchi T; Yamashita H; Ito D; Ashida K
    J Crohns Colitis; 2013 Nov; 7(10):803-11. PubMed ID: 23352104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines.
    Beltrán B; Sáez-González E; Moret I; Díaz-Jaime FC; Alvarez-Sotomayor D; Cerrillo E; Iborra M; Bastida G; Aguas M; Nos P
    J Clin Apher; 2018 Feb; 33(1):99-103. PubMed ID: 28485025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function.
    Waddell A; Vallance JE; Moore PD; Hummel AT; Wu D; Shanmukhappa SK; Fei L; Washington MK; Minar P; Coburn LA; Nakae S; Wilson KT; Denson LA; Hogan SP; Rosen MJ
    Inflamm Bowel Dis; 2015 Dec; 21(12):2737-46. PubMed ID: 26313694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
    Sakimura K; Omori T; Iwashita E; Yoshida T; Tsuzuki Y; Fujimori K; Konishi F; Yoshida Y; Anzai H; Suzuki H; Sugawara S; Takeda Y; Hiraishi K; Saniabadi AR; Ide T; Miura S; Ota S
    Dig Dis Sci; 2006 Sep; 51(9):1525-31. PubMed ID: 16902810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exclusive Enteral Nutrition: Clinical Effects and Changes in Mucosal Cytokine Profile in Pediatric New Inflammatory Bowel Disease.
    Rolandsdotter H; Jönsson-Videsäter K; L Fagerberg U; Finkel Y; Eberhardson M
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis.
    Murata Y; Ishiguro Y; Itoh J; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():56-60. PubMed ID: 8563892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
    Nakano R; Iwakiri R; Ikeda Y; Kishi T; Tsuruoka N; Shimoda R; Sakata Y; Yamaguchi K; Fujimoto K
    J Gastroenterol Hepatol; 2013 Feb; 28(2):303-8. PubMed ID: 23339387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.
    Reddy KP; Markowitz JE; Ruchelli ED; Baldassano RN; Brown KA
    Dig Dis Sci; 2007 Feb; 52(2):365-72. PubMed ID: 17219072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased mucosal expression of GATA-3 and STAT-4 in pediatric ulcerative colitis.
    Ohtani K; Ohtsuka Y; Ikuse T; Baba Y; Yamakawa Y; Aoyagi Y; Fujii T; Kudo T; Nagata S; Shimizu T
    Pediatr Int; 2010 Aug; 52(4):584-9. PubMed ID: 20030749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.